Dr. Ariane Tom is the Founder & Managing Director of Kaleida Capital, a venture capital firm investing in neurotechnology, AI, and cognitive systems shaping the future of human performance and Co-Founder & Executive Producer of Kaleida Studios, a science-driven media venture creating global narratives around technology, innovation, and the human mind.

Her work in neurotechnology began in 2008, leading original research in brain mapping, neural interfaces, and prosthetic sensing. As the first co-advised PhD student of Stanford luminaries Karl Deisseroth (optogenetics, CLARITY) and Zhenan Bao (bioelectronics), she bridged materials engineering and neuroscience in one of the earliest interdisciplinary programs of the White House BRAIN Initiative. Her contributions to brain–polymer hybrids, 3D bioelectronics, and artificial mechanoreceptors have direct relevance to today’s neurotech and AI markets, with features in Science, Nature, Scientific American, Time, and TechCrunch.

At Kaleida Capital, Ariane partners with LPs, family offices, and corporate investors to identify foresight-driven opportunities in neurotechnology, neural data infrastructure, and precision medicine. Her early investments include Manifest Technologies (acquired by JnJ) and Anthropic, a global leader in applied AI.

Through Kaleida Studios, Ariane expands her impact beyond capital markets — developing high-quality, science-inspired media projects that connect breakthrough research with global audiences, influencing both public understanding and market adoption of next-generation technologies.

A frequent speaker at internationally recognized conventions, Ariane engages audiences on accelerated computing, neuroAI, and the future of human–computer interaction. She is a member of the Milken Young Leaders Circle and an active contributor to global strategy dialogues spanning technology, finance, and public policy.